|
|
|
|
|
文献清单:“肾脏病并发症的机制与干预策略”方向 | MDPI Kidney and Dialysis |
|
|
期刊名:Kidney and Dialysis
期刊链接:https://www.mdpi.com/journal/kidneydial
还在为筛选文献而发愁?别急,这份“肾脏病并发症的机制与干预策略”方向的文献清单,也许能为您提供灵感!
本系列研究系统探索了电解质紊乱、营养代谢、心血管风险、免疫炎症及患者管理等核心领域的最新进展,涵盖从基础研究到临床实践的多元视角,为理解肾脏病并发症的病理生理机制、优化个体化干预策略及改善患者生活质量提供了重要的循证依据。
1. Etiology, Clinical Approach, and Therapeutic Consequences of Hyponatremia
低钠血症的病因、临床处理策略及治疗后果
http://www.mdpi.com/2673-8236/4/1/4
Spasovski, G. Etiology, Clinical Approach, and Therapeutic Consequences of Hyponatremia. Kidney Dial. 2024, 4, 37-45.

2. Nutritional Recommendations for Pregnant Women Receiving Dialysis: A Scoping Review
接受透析治疗的孕妇营养建议
http://www.mdpi.com/2673-8236/4/1/5
Cutajar, E.; Lambert, K. Nutritional Recommendations for Pregnant Women Receiving Dialysis: A Scoping Review. Kidney Dial. 2024, 4, 46-77.

3. How Can We Improve the Appetite of Older Patients on Dialysis in Japan?
如何改善日本老年透析患者的食欲?
http://www.mdpi.com/2673-8236/4/2/8
Kitajima, Y. How Can We Improve the Appetite of Older Patients on Dialysis in Japan? Kidney Dial. 2024, 4, 105-115.

4. IgA Nephropathy: What Is New in Treatment Options?
IgA肾病:治疗方案有何新进展?
http://www.mdpi.com/2673-8236/4/4/19
Scarpioni, R.; Valsania, T. IgA Nephropathy: What Is New in Treatment Options? Kidney Dial. 2024, 4, 223-245.

5. Dyslipidemia and Development of Chronic Kidney Disease in Non-Diabetic Japanese Adults: A 26-Year, Community-Based, Longitudinal Study
日本非糖尿病成年人的血脂异常与慢性肾病的发展
http://www.mdpi.com/2673-8236/4/4/20
Okawa, Y.; Mitsuhashi, T. Dyslipidemia and Development of Chronic Kidney Disease in Non-Diabetic Japanese Adults: A 26-Year, Community-Based, Longitudinal Study. Kidney Dial. 2024, 4, 246-256.

6. Small Interfering RNA in Kidney Diseases: Promises and Limitations
小干扰RNA在肾脏疾病中的应用
http://www.mdpi.com/2673-8236/5/1/1
Losito, A.; Solano, G. Small Interfering RNA in Kidney Diseases: Promises and Limitations. Kidney Dial. 2025, 5, 1.

7. Renal Dysfunction in Primary Aldosteronism: How, When, and Who?
原发性醛固酮增多症中的肾功能障碍
http://www.mdpi.com/2673-8236/5/1/3
Kitlinski, M.; Dreja, K.; Heleniak, Z.; Debska-Slizień, A. Renal Dysfunction in Primary Aldosteronism: How, When, and Who? Kidney Dial. 2025, 5, 3.

8. Hypercalcemia: A Practice Overview of Its Diagnosis and Causes
高钙血症:诊断和病因概述
http://www.mdpi.com/2673-8236/5/1/7
Calabrese, V.; Messina, R.M.; Cernaro, V.; Farina, A.; Di Pietro, Y.; Gembillo, G.; Longhitano, E.; Casuscelli, C.; Taverna, G.; Santoro, D. Hypercalcemia: A Practice Overview of Its Diagnosis and Causes. Kidney Dial. 2025, 5, 7.

9. Risk Factors and Potential Treatments for Fatigue in Patients with Advanced CKD: A Narrative Review
晚期慢性肾脏病患者疲劳的危险因素和潜在治疗方法
http://www.mdpi.com/2673-8236/5/1/8
Xia, A.; Meuleman, Y.; Dekker, F.W.; Hoogeveen, E.K. Risk Factors and Potential Treatments for Fatigue in Patients with Advanced CKD: A Narrative Review. Kidney Dial. 2025, 5, 8.

10. The High Correlation Between Survey Assessments for Chronic Kidney Disease-Associated Pruritus, and Its Associations with Clinical Outcomes
慢性肾脏病相关瘙痒的调查评估结果与其临床结果的关联性高度相关
http://www.mdpi.com/2673-8236/5/2/14
Wen, H.H.; Chauhan, K.; Coca, S.; Oliveira, J.; Desai, T.; Huff, K.; Chan, L. The High Correlation Between Survey Assessments for Chronic Kidney Disease-Associated Pruritus, and Its Associations with Clinical Outcomes. Kidney Dial. 2025, 5, 14.

11. Anemia Is a Predictor of Withdrawal from Peritoneal Dialysis in Stable Peritoneal Dialysis Patients
贫血是稳定腹膜透析患者退出腹膜透析的预测因素
http://www.mdpi.com/2673-8236/5/2/15
Torigoe, K.; Otsuka, E.; Tsuji, K.; Yamashita, A.; Kitamura, M.; Takazono, T.; Sakamoto, N.; Muta, K.; Mukae, H.; Nishino, T. Anemia Is a Predictor of Withdrawal from Peritoneal Dialysis in Stable Peritoneal Dialysis Patients. Kidney Dial. 2025, 5, 15.

12. Predictive Values of Handgrip Strength for Protein-Energy Wasting Among Patients Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis
握力对维持性血液透析患者蛋白质能量消耗的预测价值
http://www.mdpi.com/2673-8236/5/2/16
Ghifari, M.H.; Al-Gunaid, S.T.; Rampengan, D.D.C.H.; Wira, J.F.; Syukri, M.; Yufika, A.; Habiburrahman, M.; Iqhrammullah, M. Predictive Values of Handgrip Strength for Protein-Energy Wasting Among Patients Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis. Kidney Dial. 2025, 5, 16.

13. Risk Factors Associated with Hyporesponsiveness to Erythropoietin in Chronic Kidney Disease Patients on Hemodialysis Who Present Anemia: A Multicenter Case-Control Study
慢性肾脏病血液透析合并贫血患者对促红细胞生成素反应低下的相关危险因素
http://www.mdpi.com/2673-8236/5/2/23
Perez Tulcanaza, C.; Benítez-Baldassari, A.; Banegas-Sarmiento, A.; Sanchez, J.D. Risk Factors Associated with Hyporesponsiveness to Erythropoietin in Chronic Kidney Disease Patients on Hemodialysis Who Present Anemia: A Multicenter Case-Control Study. Kidney Dial. 2025, 5, 23.

14. Procalcitonin as a Diagnostic and Monitoring Tool for Bacteraemia in Patients on Haemodialysis: A Systematic Review
降钙素原作为血液透析患者菌血症诊断与监测工具
http://www.mdpi.com/2673-8236/5/2/24
Udofia, A.-A.; Zhang, Y. Procalcitonin as a Diagnostic and Monitoring Tool for Bacteraemia in Patients on Haemodialysis: A Systematic Review. Kidney Dial. 2025, 5, 24.

15. Advanced Chronic Kidney Disease and Patient Education
晚期慢性肾脏病与患者教育
http://www.mdpi.com/2673-8236/5/3/32
Faldu, C.T.; Knicely, D.H. Advanced Chronic Kidney Disease and Patient Education. Kidney Dial. 2025, 5, 32.

16.Truth and Pitfalls of Evidence-Based Medicine
循证医学的真相与陷阱
http://www.mdpi.com/2673-8236/5/3/38
Campese, V.M. Truth and Pitfalls of Evidence-Based Medicine. Kidney Dial. 2025, 5, 38.

Kidney and Dialysis期刊介绍:
主编: Prof. Dr. Francesco Locatelli; Former Director, Department of Nephrology and Dialysis, Alessandro Manzoni Hospital, 23900 Lecco, Italy
Kidney and Dialysis (ISSN 2673-8236)创刊于2021年,于2025年6月获得首个Impact Factor 2.2, Citescore 2.6, 是一个国际化、经同行评审的开放获取期刊。期刊聚焦肾脏病学和透析领域,重点关注常规肾功能和肾脏疾病,以及从饮食和药物到肾脏替代疗法(透析和肾移植)对肾脏健康的维护和肾脏疾病的治疗。目前,Kidney and Dialysis 期刊已被Scopus, ESCI (Web of Science), DOAJ, CNKI, OpenAIRE等数据库收录。
期刊范围包括但不限于:
慢性肾脏病(CKD)、并发症及营养;
急性肾损伤(AKI)/重症监护;
糖尿病性肾脏病;
肾小球肾炎;
妊娠与肾脏病;
高血压与肾脏病学;
肾脏疾病中的生物标志物;
透析、血液透析(HD)、腹膜透析(PD);
饮食管理与药物治疗;
肾移植;
肾脏功能与疾病的新诊断方法与技术。
|
2024 Impact Factor
|
2.2
|
|
2024 CiteScore
|
2.6
|
|
Time to First Decision
|
34.4 Days
|
|
Acceptance to Publication
|
6.3 Days
|
特别声明:本文转载仅仅是出于传播信息的需要,并不意味着代表本网站观点或证实其内容的真实性;如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任;作者如果不希望被转载或者联系转载稿费等事宜,请与我们接洽。